• 中药标准品生产商,产品定制服务
  • Science | Nature | Cell | View More

    黄芩素; 黄芩苷元

    Baicalein

    黄芩素; 黄芩苷元
    产品编号 CFN98783
    CAS编号 491-67-8
    分子式 = 分子量 C15H10O5 = 270.2
    产品纯度 >=98%
    物理属性 Yellow powder
    化合物类型 Flavonoids
    植物来源 The roots of Scutellaria baicalensis Georgi.
    ChemFaces的产品在影响因子大于5的优秀和顶级科学期刊中被引用
    提供自定义包装
    产品名称 产品编号 CAS编号 包装 QQ客服
    黄芩素; 黄芩苷元 CFN98783 491-67-8 10mg QQ客服:2932563308
    黄芩素; 黄芩苷元 CFN98783 491-67-8 20mg QQ客服:2932563308
    黄芩素; 黄芩苷元 CFN98783 491-67-8 50mg QQ客服:2932563308
    黄芩素; 黄芩苷元 CFN98783 491-67-8 100mg QQ客服:2932563308
    存储与注意事项
    1. 在您收到产品后请检查产品。如无问题,请将产品存入冰霜并且样品瓶保持密封,产品可以存放长达24个月(2-8摄氏度)。

    2. 只要有可能,产品溶解后,您应该在同一天应用于您的实验。 但是,如果您需要提前做预实验,或者需要全部溶解,我们建议您将溶液以等分试样的形式存放在-20℃的密封小瓶中。 通常,这些可用于长达两周。 使用前,打开样品瓶前,我们建议您将产品平衡至室温至少1小时。

    3. 需要更多关于溶解度,使用和处理的建议? 请发送电子邮件至:service@chemfaces.com
    订购流程
  • 1. 在线订购
  • 请联系我们QQ客服

  • 2. 电话订购
  • 请拨打电话:
    027-84237683 或 027-84237783

  • 3. 邮件或传真订购
  • 发送电子邮件到: manager@chemfaces.com 或
    发送传真到:027-84254680

  • 提供订购信息
  • 为了方便客户的订购,请需要订购ChemFaces产品的客户,在下单的时候请提供下列信息,以供我们快速为您建立发货信息。
  •  
  • 1. 产品编号(CAS No.或产品名称)
  • 2. 发货地址
  • 3. 联系方法 (联系人,电话)
  • 4. 开票抬头 (如果需要发票的客户)
  • 5. 发票地址(发货地址与发票地址不同)
  • 发货时间
    1. 付款方式为100%预付款客户,我们将在确认收到货款后当天或1-3个工作日发货。

    2. 付款方式为月结的客户,我们承诺在收到订单后当天或1-3个工作日内发货。

    3. 如果客户所需要的产品,需要重新生产,我们有权告知客户,交货时间需要延期。
    ChemFaces的产品在许多优秀和顶级科学期刊中被引用

    Cell. 2018 Jan 11;172(1-2):249-261.e12.
    doi: 10.1016/j.cell.2017.12.019.
    IF=36.216(2019)

    PMID: 29328914

    Cell Metab. 2020 Mar 3;31(3):534-548.e5.
    doi: 10.1016/j.cmet.2020.01.002.
    IF=22.415(2019)

    PMID: 32004475

    Mol Cell. 2017 Nov 16;68(4):673-685.e6.
    doi: 10.1016/j.molcel.2017.10.022.
    IF=14.548(2019)

    PMID: 29149595

    ACS Nano. 2018 Apr 24;12(4): 3385-3396.
    doi: 10.1021/acsnano.7b08969.
    IF=13.903(2019)

    PMID: 29553709

    Nature Plants. 2016 Dec 22;3: 16206.
    doi: 10.1038/nplants.2016.205.
    IF=13.297(2019)

    PMID: 28005066

    Sci Adv. 2018 Oct 24;4(10): eaat6994.
    doi: 10.1126/sciadv.aat6994.
    IF=12.804(2019)

    PMID: 30417089
    我们的产品现已经出口到下面的研究机构与大学,并且还在增涨
  • Sri Ramachandra University (India)
  • The University of Newcastle (Australia)
  • University of Maryland School of Medicine (USA)
  • Chinese University of Hong Kong (China)
  • Uniwersytet Medyczny w ?odzi (Poland)
  • University of Queensland (Australia)
  • Osmania University (India)
  • Nanjing University of Chinese Medicine (China)
  • University of Maryland (USA)
  • Florida A&M University (USA)
  • Guangzhou Institutes of Biomedicine and Health (China)
  • University of Limpopo (South Africa)
  • Mahidol University (Thailand)
  • Funda??o Universitária de Desenvolvimento (Brazil)
  • More...
  • 国外学术期刊发表的引用ChemFaces产品的部分文献
  • Molecules. 2013, 18(7):7376-88
  • BMC Complement Altern Med.2014, 14:242
  • Exp Parasitol.2015, 153:160-4
  • Molecules.2016, 21(6)
  • Anal Bioanal Chem. 2016, 408(15)
  • PLoS One.2018, 13(4):e0195642
  • Pharmacognosy Magazine2018, 14(56):418-424
  • Phytomedicine.2018, 38:12-23
  • Sci Rep.2018, 8:15059
  • Biochemical Systematics and Ecology2018, 81
  • J Sci Food Agric.2018, 98(3):1153-1161
  • Journal of Ginseng Research2019, 10.1016
  • Biomol Ther (Seoul).2019, 10.4062
  • Enzyme Microb Technol.2019, 122:64-73
  • Molecules.2019, 24(20):3755
  • Cell Chem Biol.2019, 26(1):27-34
  • J Enzyme Inhib Med Chem.2019, 34(1):134-143
  • Chin J Pharm Anal.2019, 39(7):1217-1228
  • J Funct Foods2019, 54:449-456
  • Plos One.2019, 15(2):e0220084
  • Crystals2020, 10(3), 206.
  • J Vet Sci.2020, 21(3):e39.
  • Molecules.2020, 25(21):5087.
  • ...
  • 生物活性
    Description: Baicalein has neuroprotective, anticancer, antioxidant and free radical scavenging effects, it inhibits mTORC1 pathway and PI3K kinase activity. Baicalein is mainly due to autophagic cell death through activation of the AMPK/ULK1 pathway and inhibition of mTOR/Raptor complex 1 expression; it can induce cancer cell death and proliferation retardation by the inhibition of CDC2 kinase and survivin associated with opposite role of p38 mitogen-activated protein kinase and AKT.
    Targets: p53 | PI3K | mTOR | ERK | Calcium Channel | p38MAPK | Akt | AMPK | Wnt/β-catenin | GSK-3
    In vitro:
    Cancer Lett. 2015 Mar 28;358(2):170-9.
    Baicalein upregulates DDIT4 expression which mediates mTOR inhibition and growth inhibition in cancer cells.[Pubmed: 25543165]
    Baicalein is a natural flavone that exhibits anticancer properties. Using microarrays we found that DDIT4 was the highest transcript induced by baicalein in cancer cells.
    METHODS AND RESULTS:
    We confirmed in multiple cancer cell lines large, dose-related expression of DDIT4 by quantitative RT-PCR and immunoblot, which correlates with growth inhibition. Time course experiments demonstrate that DDIT4 is rapidly inducible, with high expression maintained for several days in vitro. Induction of DDIT4 expression is p53 independent based on evaluation of p53 knockout cells. Since DDIT4 is known to inhibit mTORC1 activity we confirmed that baicalein suppresses phosphorylation of mTORC1 targets. Using RNA interference we demonstrate that mTORC1 activity and growth inhibition by baicalein is attenuated by knockdown of DDIT4. We furthermore demonstrate suppression of established tumors by baicalein in a mouse model of breast cancer with increased DDIT4 expression in the tumors. Finally, we demonstrate that baicalein upregulates DDIT4 and causes mTORC1 and growth inhibition in platinum resistant cancer cells in marked contrast to platinum chemotherapy treatment.
    CONCLUSIONS:
    These studies demonstrate that baicalein inhibits mTORC1 through DDIT4 expression, and may be useful in cancer chemotherapy and chemoprevention.
    Biochem Pharmacol. 2014 Nov 15;92(2):251-65.
    Baicalein inhibits agonist- and tumor cell-induced platelet aggregation while suppressing pulmonary tumor metastasis via cAMP-mediated VASP phosphorylation along with impaired MAPKs and PI3K-Akt activation.[Pubmed: 25268843]
    Recently, the importance of platelet activation in cancer metastasis has become generally accepted. As a result, the development of new platelet inhibitors with minimal adverse effects is now a promising area of targeted cancer therapy. Baicalein is a functional ingredient derived from the root of Scutellaria baicalensis Georgi, a plant used intraditional medicine. The pharmacological effects of this compound including anti-oxidative and anti-inflammatory activities have already been demonstrated. However, its effects on platelet activation are unknown. We therefore investigated the effects of baicalein on ligand-induced platelet aggregation and pulmonary cancer metastasis.
    METHODS AND RESULTS:
    In the present study, baicalein inhibited agonist-induced platelet aggregation, granule secretion markers (P-selectin expression and ATP release), [Ca(2+)]i mobilization, and integrin αIIbβ3 expression. Additionally, baicalein attenuated ERK2, p38, and Akt activation, and enhanced VASP phosphorylation. Indeed, baicalein was shown to directly inhibit PI3K kinase activity. Moreover, baicalein attenuated the platelet aggregation induced by C6 rat glioma tumor cells in vitro and suppressed CT26 colon cancer metastasis in mice.
    CONCLUSIONS:
    These features indicate that baicalein is a potential therapeutic drug for the prevention of cancer metastasis.
    Phytother Res. 2014 Sep;28(9):1342-8.
    Anticancer effects of baicalein on hepatocellular carcinoma cells.[Pubmed: 24596136]
    The therapeutic potential of baicalein against hepatoma cells was evaluated in vitro and in vivo.
    METHODS AND RESULTS:
    In cell viability assays, baicalein showed significant cytotoxicity against the hepatocellular carcinoma cell lines H22, Bel-7404, and Hep G2 and moderate cytotoxicity against immortalized human hepatocytes. Baicalein induced G0/G1-phase arrest in hepatocellular carcinoma cells, inhibited AKT, and promoted the degradation of β-catenin and cyclin D1 without activation of GSK-3β. Furthermore, baicalein significantly inhibited H22 xenograft tumor growth without causing obvious adverse effects on weight or liver and spleen weight indexes in ICR mice. Immunohistochemical analysis showed that the inhibition of tumor growth in baicalein-treated mice was associated with decreased AKT, β-catenin, and cyclin D1 expression ex vivo. Our data indicate that baicalein might regulate cyclin D1 transcription via a β-catenin-dependent mechanism, leading to cell cycle arrest at G0/G1 phase and impaired cancer cell proliferation.
    CONCLUSIONS:
    These results suggest that baicalein is a potential candidate for the treatment of hepatocellular carcinoma.
    Anticancer Res. 2000 Sep-Oct;20(5A):2861-5.
    Antioxidant and free radical scavenging effects of baicalein, baicalin and wogonin.[Pubmed: 11062694]
    Xanthine oxidase inhibitors are known to be therapeutically useful for the treatment of hepatitis and brain tumor. Baicalein, baicalin and wogonin, isolated from Scutellaria rivularis, have been reported to exhibit a strong activity on xanthine oxidase inhibition.
    METHODS AND RESULTS:
    In this study, their antioxidant activity was evaluated by modified xanthine oxidase inhibition and cytochrome c reduced methods. The results showed that the order of activity on xanthine oxidase inhibition was baicalein > wogonin > baicalin, IC50 = 3.12, 157.38 and 215.19 microM, respectively, whereas the activity on cytochrome c reduction was baicalin > wogonin > baicalein (IC50 = 224.12, 300.10 and 370.33 microM, respectively). In another study, an electron spin resonance (ESR) technique was used to further confirm the direct free radical scavenging activity. Both baicalein and baicalin demonstrated a strong activity on eliminating the superoxide radical (.O2-) (baicalein: 7.31 x 10(4) u/g; baicalin: 1.19 x 10(5) u/g). The IC50 of baicalein was 2.8 fold higher than that of baicalin. However they had no significant effect on scavenging hydroxyl radical (.OH).
    CONCLUSIONS:
    The present results demonstrated that baicalein and baicalin posed a different pathological pathway. The antioxidant function of baicalin was mainly based on scavenging superoxide radical whilst baicalein was a good xanthine oxidase inhibitor.
    In vivo:
    Pharmacol Biochem Behav. 2015 Jun;133:155-63.
    Ameliorative effects of baicalein in MPTP-induced mouse model of Parkinson's disease: A microarray study.[Pubmed: 25895692 ]
    Baicalein, a flavonoid from Scutellaria baicalensis Georgi, has been shown to possess neuroprotective properties.
    METHODS AND RESULTS:
    The purpose of this study was to explore the effects of baicalein on motor behavioral deficits and gene expression in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mice model of Parkinson's disease (PD). The behavioral results showed that baicalein significantly improves the abnormal behaviors in MPTP-induced mice model of PD, as manifested by shortening the total time for climbing down the pole, prolonging the latent periods of rotarod, and increasing the vertical movements. Using cDNA microarray and subsequent bioinformatic analyses, it was found that baicalein significantly promotes the biological processes including neurogenesis, neuroblast proliferation, neurotrophin signaling pathway, walking and locomotor behaviors, and inhibits dopamine metabolic process through regulation of gene expressions. Based on analysis of gene co-expression networks, the results indicated that the regulation of genes such as LIMK1, SNCA and GLRA1 by baicalein might play central roles in the network.
    CONCLUSIONS:
    Our results provide experimental evidence for the potential use of baicalein in the treatment of PD, and revealed gene expression profiles, biological processes and pathways influenced by baicalein in MPTP-treated mice.
    制备储备液(仅供参考)
    1 mg 5 mg 10 mg 20 mg 25 mg
    1 mM 3.701 mL 18.5048 mL 37.0096 mL 74.0192 mL 92.5241 mL
    5 mM 0.7402 mL 3.701 mL 7.4019 mL 14.8038 mL 18.5048 mL
    10 mM 0.3701 mL 1.8505 mL 3.701 mL 7.4019 mL 9.2524 mL
    50 mM 0.074 mL 0.3701 mL 0.7402 mL 1.4804 mL 1.8505 mL
    100 mM 0.037 mL 0.185 mL 0.3701 mL 0.7402 mL 0.9252 mL
    * Note: If you are in the process of experiment, it's need to make the dilution ratios of the samples. The dilution data of the sheet for your reference. Normally, it's can get a better solubility within lower of Concentrations.
    部分图片展示
    产品名称 产品编号 CAS编号 分子式 = 分子量 位单 联系QQ
    6,7-二羟基黄酮; 6,7-Dihydroxyflavone CFN70351 38183-04-9 C15H10O4 = 254.2 5mg QQ客服:1413575084
    7,8-二羟基黄酮; 7,8-Dihydroxyflavone CFN96512 38183-03-8 C15H10O4 = 254.24 20mg QQ客服:2932563308
    白杨素; Chrysin CFN98741 480-40-0 C15H10O4 = 254.2 20mg QQ客服:2159513211
    5-羟基-7-乙酰氧基黄酮; 5-Hydroxy-7-acetoxyflavone CFN97139 6674-40-4 C17H12O5 = 296.3 5mg QQ客服:2159513211
    5-乙酰氧基-7-羟基黄酮; 5-Acetoxy-7-hydroxyflavone CFN99409 132351-58-7 C17H12O5 = 296.3 5mg QQ客服:1457312923
    5,7-二乙酰氧基黄酮; 5,7-Diacetoxyflavone CFN97138 6665-78-7 C19H14O6 = 338.3 5mg QQ客服:2056216494
    柚木柯因; Tectochrysin CFN98840 520-28-5 C16H12O4 = 268.3 20mg QQ客服:2056216494
    柯因二甲醚; Chrysin dimethylether CFN90896 21392-57-4 C17H14O4 = 282.3 20mg QQ客服:2159513211
    去甲汉黄芩素; Norwogonin CFN92218 4443-09-8 C15H10O5 = 270.2 10mg QQ客服:2056216494
    汉黄芩素; Wogonin CFN97089 632-85-9 C16H12O5 = 284.3 20mg QQ客服:2932563308

    信息支持


    公司简介
    订购流程
    付款方式
    退换货政策

    ChemFaces提供的产品仅用于科学研究使用,不用于诊断或治疗程序。

    联系方式


    电机:027-84237783
    传真:027-84254680
    在线QQ1: 2056216494 ; QQ2: 3257982914
    E-Mail:manager@chemfaces.com

    湖北省武汉沌口经济技术开区车城南路83号1号楼第三层厂房


    ChemFaces为科学家,科研人员与企业提供快速的产品递送。我们通过瑞士SGS ISO 9001:2008质量体系认证天然化合物与对照品的研发和生产